{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:16:17Z","timestamp":1791404177988,"version":"4.3.3"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T00:00:00Z","timestamp":1341964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0040781","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T20:58:28Z","timestamp":1342040308000},"page":"e40781","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":76,"title":["Adverse Events among HIV\/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India"],"prefix":"10.1371","volume":"7","author":[{"given":"Petros","family":"Isaakidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanumati","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Ladomirska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Saranchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esdras","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samsuddin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Paryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarir","family":"Udwadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Migliori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sotgiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,7,11]]},"reference":[{"key":"ref1","first-page":"153","article-title":"Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis Lancet Infect Dis","volume":"9","author":"EW Orenstein","year":"2009"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e6914","DOI":"10.1371\/journal.pone.0006914","article-title":"Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis.","volume":"4(9)","author":"JC Johnston","year":"2009","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e7186","DOI":"10.1371\/journal.pone.0007186","article-title":"Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa.","volume":"4(9)","author":"KJ Seung","year":"2009","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e28066","DOI":"10.1371\/journal.pone.0028066","article-title":"Ambulatory Multi-drug Resistant Tuberculosis Treatment Outcomes In A Cohort Of HIV-Infected Patients In A Slum Setting In Mumbai, India.","volume":"6(12)","author":"P Isaakidis","year":"2011","journal-title":"PLoS One"},{"key":"ref5","article-title":"Guidelines for the programmatic management of drug-resistant tuberculosis Emergency Update 2008.","year":"2008"},{"key":"ref6","article-title":"Management of MDR-TB: a field guide. A companion document to Guidelines for the Programmatic Management of Drug-resistant Tuberculosis (WHO\/HTM\/TB\/2008.402a).","year":"2009"},{"key":"ref7","first-page":"1382","article-title":"Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative.","volume":"8(11)","author":"E Nathanson","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref8","first-page":"648","article-title":"Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis.","volume":"5(7)","author":"JJ Furin","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref9","first-page":"1373","article-title":"Side effects associated with the treatment of multidrug-resistant tuberculosis.","volume":"9(12)","author":"T Torun","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref10","first-page":"1314","article-title":"Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia.","volume":"Dis11(12)","author":"SS Shin","year":"2007","journal-title":"Int J Tuberc Lung"},{"key":"ref11","first-page":"5","article-title":"Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. BMC Ear Nose Throat Disord.","volume":"7","author":"P Duggal","year":"2007","journal-title":"12"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5588\/ijtld.11.0473","article-title":"HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.","volume":"16(3)","author":"E Palacios","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref13","article-title":"Guidelines for the programmatic management of drug-resistant tuberculosis, 2011 Update.","year":"2011"},{"key":"ref14","article-title":"Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. 2010 revision.","year":"2010"},{"key":"ref15","first-page":"640","article-title":"Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.","volume":"9(6)","author":"KF Laserson","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref16","first-page":"976","article-title":"Seven-year DOTS-Plus pilot experience in India: results, constraints and issues Int J Tuberc Lung Dis","volume":"13(8)","author":"R Singla","year":"2009"},{"key":"ref17","first-page":"529","article-title":"Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.","volume":"Res133(5)","author":"P Joseph","year":"2011","journal-title":"Indian J Med"},{"key":"ref18","first-page":"170","article-title":"The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med.","volume":"345(3)","author":"K Tahao\u011flu","year":"2001"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e1126","DOI":"10.1371\/journal.pone.0001126","article-title":"Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures.","volume":"2(11)","author":"HS Cox","year":"2007","journal-title":"PloS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0140-6736(91)92447-A","article-title":"Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis.","volume":"(8742)","author":"P Nunn","year":"1991","journal-title":"Lancet 337"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1258\/ijsa.2008.008361","article-title":"Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs.","volume":"20(5)","author":"DJ Marks","year":"2009","journal-title":"Int J STD AIDS"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.5588\/ijtld.11.0615","article-title":"High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho.","author":"H Satti","year":"2012"},{"key":"ref23","first-page":"e7","article-title":"Mismanagement of tuberculosis in India: Causes, consequences, and the way forward.","volume":"9(1)","author":"A Bhargava","year":"2011","journal-title":"Hypothesis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e12023","DOI":"10.1371\/journal.pone.0012023","article-title":"Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades?","volume":"5(8)","author":"ZF Udwadia","year":"2010","journal-title":"PLoS One"},{"key":"ref25","first-page":"283","article-title":"Efficacy of utilising patient self-report of auditory complaints to monitor aminoglycoside ototoxicity. Int J Tuberc Lung Dis.","volume":"16(2)","author":"LD Ramma","year":"2012"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14992020600860935","article-title":"The accuracy of self-reported hearing loss in older Latino-American adults.","volume":"45(10)","author":"P Torre","year":"2006","journal-title":"Int J Audiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0040781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T21:06:46Z","timestamp":1561928806000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0040781"}},"subtitle":[],"editor":[{"given":"Robert J.","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,11]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0040781","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,11]]}}}